Seeger Weiss Announces New Partner and Counsel

Seeger Weiss is pleased to announce the promotion of Parvin K. Aminolroaya to partner and Asim M. Badaruzzaman to counsel. About Parvin Parvin focuses on class action, mass tort and complex commercial litigation involving consumer protection, investment fraud, and antitrust and pharmaceutical injury. Parvin joined the firm as an associate in the fall of 2008 […]

January 2, 2019

Seeger Weiss is pleased to announce the promotion of Parvin K. Aminolroaya to partner and Asim M. Badaruzzaman to counsel.

About Parvin

Parvin focuses on class action, mass tort and complex commercial litigation involving consumer protection, investment fraud, and antitrust and pharmaceutical injury.

Parvin joined the firm as an associate in the fall of 2008 following her graduation from Cardozo Law School, where she served as an Editorial Board Member of the Moot Court Honor Society.

She is a recipient of the 2016 Alumni Association Young Leadership Award, the Jacob Burns Medal for outstanding contribution to Moot Court, and the 2018 Cardozo Game Changer award by the Cardozo Law School Black, Asian, Latino Law Students Association Alumni Group (BALLSA). She is the former Vice-Chair of BALLSA and the current Co-Chair of Cardozo Women.

Her full bio and selected representations can be read here.

About Asim

Asim practices in the areas of pharmaceutical drug injury, medical device liability, and mass tort litigation.

Asim joined the firm as a law clerk in 2008 and became an associate in 2010 after receiving his law degree from Seton Hall, where he participated in the Civil Litigation Clinic at the Center for Social Justice and was recognized as the Best Brief Author in appellate advocacy.

He graduated with honors from Rutgers University in 2006 with a major in political science.

His full bio and selected representations can be read here.

Speaking on behalf of the partners, founding partner Chris Seeger said; “Through the years, Parvin has been a strong and effective advocate for our clients, and a valued colleague to us all. Likewise, Asim has led our client team with his ever-present commitment, compassion, and judgment. We’re thankful for their many contributions to our clients and the firm, and look forward to their future success.”

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More